80_FR_64010 80 FR 63807 - National Cancer Institute; Notice of Closed Meetings

80 FR 63807 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 203 (October 21, 2015)

Page Range63807-63808
FR Document2015-26721

Federal Register, Volume 80 Issue 203 (Wednesday, October 21, 2015) 
[Federal Register Volume 80, Number 203 (Wednesday, October 21, 2015)]
[Notices]
[Pages 63807-63808]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-26721]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Collaborative Research in Integrative Cancer Biology (U01).
    Date: November 19, 2015.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 63808]]

    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W264, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Reed Graves, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-6384, 
gravesr@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Biomarker Development and Validation.
    Date: December 2, 2015.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-6371, 
decluej@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 16, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-26721 Filed 10-20-15; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices 63807 Agencies to provide a 60-day notice in collection of information, including the (Pub. L. 107–250) was signed into law the Federal Register concerning each validity of the methodology and on October 26, 2002. Section 201 of proposed collection of information, assumptions used; (3) ways to enhance MDUFMA added a new paragraph (g) to including each proposed extension of an the quality, utility, and clarity of the section 704 of the Federal, Food, Drug, existing collection of information, information to be collected; and (4) and Cosmetic Act (21 U.S.C. 374), before submitting the collection to OMB ways to minimize the burden of the directing FDA to accredit third parties for approval. To comply with this collection of information on (accredited persons) to conduct requirement, FDA is publishing notice respondents, including through the use inspections of eligible manufacturers of of the proposed collection of of automated collection techniques, class II or class III devices. FDA’s information set forth in this document. when appropriate, and other forms of guidance document entitled With respect to the following information technology. ‘‘Implementation of the Inspection by collection of information, FDA invites Accredited Persons Program Under the Inspection by Accredited Persons comments on these topics: (1) Whether Medical Device User Fee and Program Under the Medical Device the proposed collection of information Modernization Act of 2002; User Fee and Modernization Act of is necessary for the proper performance Accreditation Criteria’’ provides 2002—OMB Control Number 0910– of FDA’s functions, including whether information for those interested in 0510—Extension the information will have practical participating in this voluntary program. utility; (2) the accuracy of FDA’s The Medical Device User Fee and FDA estimates the burden of this estimate of the burden of the proposed Modernization Act of 2002 (MDUFMA) collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of Average Number of Total annual Activity responses per burden per Total hours respondents responses respondent response Request for accreditation ..................................................... 1 1 1 80 80 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Dated: October 15, 2015. attendee.gotowebinar.com/register/ Dated: October 9, 2015. Leslie Kux, 7500158409923624193. Register to Ben O’Dell, Associate Commissioner for Policy. participate in the conference call on Associate Director. [FR Doc. 2015–26641 Filed 10–20–15; 8:45 am] Friday, November 6th at the Web site [FR Doc. 2015–26407 Filed 10–20–15; 8:45 am] BILLING CODE 4164–01–P https://attendee.gotowebinar.com/ BILLING CODE 4154–07–P register/8566024981889767937. Status: Open to the public, limited DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND only by space available. Conference call HUMAN SERVICES HUMAN SERVICES limited only by lines available. Meeting Notice for the President’s Purpose: The Council brings together National Institutes of Health Advisory Council on Faith-based and leaders and experts in fields related to Neighborhood Partnerships the work of faith-based and National Cancer Institute; Notice of neighborhood organizations in order to: Closed Meetings In accordance with section 10(a)(2) of the Federal Advisory Committee Act Identify best practices and successful Pursuant to section 10(d) of the (Pub. L. 92–463), the President’s modes of delivering social services; Federal Advisory Committee Act, as Advisory Council on Faith-based and evaluate the need for improvements in amended (5 U.S.C. App.), notice is Neighborhood Partnerships announces the implementation and coordination of hereby given of the following meetings. the following meetings: public policies relating to faith-based The meetings will be closed to the Name: President’s Advisory Council and other neighborhood organizations; public in accordance with the on Faith-based and Neighborhood and make recommendations for changes provisions set forth in sections Partnerships Council Meetings in policies, programs, and practices. 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Time and Date: Thursday, November as amended. The grant applications and 5th, 2015 1:00 p.m.–4:30 p.m. (EST) and Contact Person for Additional Information: Please contact Ben O’Dell the discussions could disclose Friday, November 6th, 2015 9:30 a.m.– confidential trade secrets or commercial 12:30 p.m. (EST) for any additional information about the President’s Advisory Council meeting at property such as patentable material, Place: Meeting will be held at a and personal information concerning location to be determined in the White partnerships@hhs.gov individuals associated with the grant House complex, 1600 Pennsylvania Agenda: More information for the applications, the disclosure of which Ave. NW., Washington, DC. Space is agenda for the meeting will be provided would constitute a clearly unwarranted extremely limited. Photo ID and RSVP to those who register to attend in person invasion of personal privacy. are required to attend the event. Please or by conference call. Name of Committee: National Cancer tkelley on DSK3SPTVN1PROD with NOTICES RSVP to Ben O’Dell at partnerships@ hhs.gov Public Comment: There will be an Institute Special Emphasis Panel; opportunity for public comment at the Collaborative Research in Integrative Cancer The meeting will be available to the Biology (U01). public through a conference call line. end of the meeting. Comments and Date: November 19, 2015. Register to participate in the conference questions can be sent in advance to Time: 11:00 a.m. to 6:00 p.m. call on Thursday, November 5th at the partnerships@hhs.gov. Agenda: To review and evaluate grant Web site https:// applications. VerDate Sep<11>2014 22:39 Oct 20, 2015 Jkt 238001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1

63808 Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices Place: National Cancer Institute Shady Name of Committee: Center for Scientific Place: Bethesda Marriott, 5151 Pooks Hill Grove, 9609 Medical Center Drive, Room Review Special Emphasis Panel, Small Road, Bethesda, MD 20814. 7W264, Rockville, MD 20850 (Telephone Business: Non HIV Microbial Vaccines and Contact Person: Lawrence Ka-Yun Ng, Conference Call). Countermeasures. Ph.D., Scientific Review Officer, Center for Contact Person: Reed Graves, Ph.D., Date: November 12, 2015. Scientific Review, National Institutes of Scientific Review Officer, Research Time: 8:00 a.m. to 6:30 p.m. Health, 6701 Rockledge Drive, Room 6152, Technology and Contract Review Branch, Agenda: To review and evaluate grant MSC 7804, Bethesda, MD 20892, 301–435– Division of Extramural Activities, National applications. 1719, ngkl@csr.nih.gov. Cancer Institute, 9609 Medical Center Drive, Place: Bethesda North Marriott Hotel & Name of Committee: Center for Scientific Room 7W264, Bethesda, MD 20892–9750, Conference Center, Montgomery County Review Special Emphasis Panel, PAR–14– 240–276–6384, gravesr@mail.nih.gov. Conference Center Facility, 5701 Marinelli 080 International Research in Infectious Name of Committee: National Cancer Road, North Bethesda, MD 20852. Diseases including AIDS (IRIDA). Institute Special Emphasis Panel; Cancer Contact Person: Andrea Keane-Myers, Date: November 16, 2015. Biomarker Development and Validation. Ph.D., Scientific Review Officer, Center for Time: 8:00 a.m. to 6:00 p.m. Date: December 2, 2015. Scientific Review, National Institutes of Agenda: To review and evaluate grant Time: 11:00 a.m. to 3:00 p.m. Health, 6701 Rockledge Drive, Room 4218, applications. Agenda: To review and evaluate grant Bethesda, MD 20892, 301–435–1221, Place: Embassy Suites Hotel, Chevy Chase applications. andrea.keane-myers@nih.gov. Pavilion, 4300 Military Road NW., Place: National Cancer Institute Shady Name of Committee: Center for Scientific Washington, DC 20015. Grove, 9609 Medical Center Drive, Room Review Special Emphasis Panel, Small Contact Person: Soheyla Saadi, Ph.D., 4W034, Rockville, MD 20850 (Telephone Business: Radiation Therapy and Biology. Scientific Review Officer, Center for Conference Call). Date: November 12–13, 2015. Scientific Review, National Institutes of Contact Person: Jeffrey E. DeClue, Ph.D., Time: 9:00 a.m. to 11:00 p.m. Health, 6701 Rockledge Drive, Room 3211, Scientific Review Officer, Research Agenda: To review and evaluate grant MSC 7808, Bethesda, MD 20892, 301–435– Technology and Contract Review Branch, applications. 0903, saadisoh@csr.nih.gov. Division of Extramural Activities, National Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific Cancer Institute, NIH, 9609 Medical Center Rockledge Drive, Bethesda, MD 20892, Review Special Emphasis Panel, Member Drive, Room 7W238, Bethesda, MD 20892– (Virtual Meeting). Conflict: Pathogenic Eukaryotes and Vectors. 9750, 240–276–6371, decluej@mail.nih.gov. Contact Person: Bo Hong, Ph.D., Scientific Date: November 16, 2015. (Catalogue of Federal Domestic Assistance Review Officer, Center for Scientific Review, Time: 10:00 a.m. to 6:00 p.m. Program Nos. 93.392, Cancer Construction; National Institutes of Health, 6701 Rockledge Agenda: To review and evaluate grant 93.393, Cancer Cause and Prevention Drive, Room 6194, MSC 7804, Bethesda, MD applications. Research; 93.394, Cancer Detection and 20892, 301–996–6208, hongb@csr.nih.gov. Place: National Institutes of Health, 6701 Diagnosis Research; 93.395, Cancer Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892. Treatment Research; 93.396, Cancer Biology Review Special Emphasis Panel, Small Contact Person: John C Pugh, Ph.D., Research; 93.397, Cancer Centers Support; Business PAR Panel: Safe and Effective Scientific Review Officer, Center for 93.398, Cancer Research Manpower; 93.399, Instruments and Devices for Use in Neonatal Scientific Review, National Institutes of Cancer Control, National Institutes of Health, and Pediatric Care Settings. Health, 6701 Rockledge Drive, Room 3114, HHS) Date: November 12, 2015. MSC 7808, Bethesda, MD 20892, (301) 435– Time: 11:00 a.m. to 5:00 p.m. 2398, pughjohn@csr.nih.gov. Dated: October 16, 2015. Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance Melanie J. Gray, applications. Program Nos. 93.306, Comparative Medicine; Program Analyst, Office of Federal Advisory Place: National Institutes of Health, 6701 93.333, Clinical Research, 93.306, 93.333, Committee Policy. Rockledge Drive, Bethesda, MD 20892, 93.337, 93.393–93.396, 93.837–93.844, [FR Doc. 2015–26721 Filed 10–20–15; 8:45 am] (Virtual Meeting). 93.846–93.878, 93.892, 93.893, National Contact Person: John Firrell, Ph.D., Institutes of Health, HHS) BILLING CODE 4140–01–P Scientific Review Officer, Center for Dated: October 15, 2015. Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, Carolyn Baum, DEPARTMENT OF HEALTH AND MSC 7854, Bethesda, MD 20892, 301–435– Program Analyst, Office of Federal Advisory HUMAN SERVICES 2598, firrellj@csr.nih.gov. Committee Policy. Name of Committee: Center for Scientific [FR Doc. 2015–26630 Filed 10–20–15; 8:45 am] National Institutes of Health Review Special Emphasis Panel, Small BILLING CODE 4140–01–P Business: Non-HIV Infectious Diseases Center for Scientific Review; Notice of Therapeutics. Closed Meetings Date: November 12, 2015. DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the Time: 1:00 p.m. to 4:00 p.m. HUMAN SERVICES Agenda: To review and evaluate grant Federal Advisory Committee Act, as applications. amended (5 U.S.C. App.), notice is National Institutes of Health Place: Hilton Garden Inn Bethesda, 7301 hereby given of the following meetings. Waverly Street, Bethesda, MD 20814. The meetings will be closed to the National Institute of Allergy and Contact Person: Gagan Pandya, Ph.D., public in accordance with the Scientific Review Officer, National Institutes Infectious Diseases; Notice of Closed provisions set forth in sections of Health, Center for Scientific Review, 6701 Meeting 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Rockledge Drive, Room 3200, MSC 7808, Pursuant to section 10(d) of the as amended. The grant applications and Bethesda, MD 20892, 301–435–1167, Federal Advisory Committee Act, as pandyaga@mai.nih.gov. the discussions could disclose amended (5 U.S.C. App.), notice is Name of Committee: Center for Scientific tkelley on DSK3SPTVN1PROD with NOTICES confidential trade secrets or commercial hereby given of the following meeting. Review Special Emphasis Panel, RFA–OD– property such as patentable material, The meeting will be closed to the 15–004—Tobacco Regulatory Science Small and personal information concerning Grant Program for New Investigators (R03). public in accordance with the individuals associated with the grant Date: November 16, 2015. provisions set forth in sections applications, the disclosure of which Time: 8:00 a.m. to 6:00 p.m. 552b(c)(4) and 552b(c)(6), title 5 U.S.C., would constitute a clearly unwarranted Agenda: To review and evaluate grant as amended. The grant applications and invasion of personal privacy. applications. the discussions could disclose VerDate Sep<11>2014 22:39 Oct 20, 2015 Jkt 238001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1


Document Created: 2018-02-27 08:54:00
Document Modified: 2018-02-27 08:54:00
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 19, 2015.
FR Citation80 FR 63807 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR